D3Ertd751e Inhibitors
D3Ertd751e inhibitors are a class of compounds that specifically target the protein or molecule identified as D3Ertd751e. Though detailed information about D3Ertd751e may not be widely available, it is likely that it plays a role in a specific cellular or molecular pathway, possibly related to enzymatic functions or protein interactions. Inhibitors designed for D3Ertd751e function by binding to key sites on the molecule, disrupting its normal activity and preventing it from carrying out its biological role. These inhibitors may alter molecular pathways or regulatory mechanisms that involve D3Ertd751e, offering insights into the functional importance of this protein in various cellular processes.
The mechanism by which D3Ertd751e inhibitors operate typically involves interaction with the protein's active or allosteric sites. These inhibitors may block the active site of D3Ertd751e, preventing it from interacting with substrates or cofactors necessary for its function. Alternatively, allosteric inhibitors may bind to different regions of the protein, causing a conformational change that reduces or eliminates its activity. By inhibiting D3Ertd751e, researchers can observe the downstream effects of its reduced function, helping to clarify the role this protein plays in broader biological systems such as signaling pathways, metabolic processes, or structural regulation. The study of D3Ertd751e inhibitors thus contributes to a deeper understanding of molecular networks and the specific role of D3Ertd751e within those contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D, a potent RNA polymerase inhibitor, directly targets RNA polymerase II. Its interference with transcription elongation indirectly hampers D3Ertd751e's DNA-binding transcription activator activity, affecting its role in the regulation of RNA polymerase II-mediated transcription processes. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin, known for inhibiting RNA polymerase II, directly targets the polymerase complex. Its strong binding obstructs mRNA synthesis, indirectly impacting D3Ertd751e's DNA-binding transcription activator function and its involvement in the regulation of transcription by RNA polymerase II. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide, an RNA polymerase II inhibitor, directly targets RNA polymerase II, suppressing transcriptional activity. Its impact on the polymerase indirectly influences D3Ertd751e's DNA-binding transcription activator activity and its regulatory function in transcription by RNA polymerase II. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646, a histone acetyltransferase (HAT) inhibitor, directly targets p300/CBP-associated factor (PCAF). By inhibiting PCAF, C646 disrupts histone acetylation, indirectly influencing D3Ertd751e's DNA-binding transcription activator activity and its regulatory role in transcription by RNA polymerase II. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol, a CDK inhibitor, directly targets CDK9. Its impact on CDK9 alters the phosphorylation process associated with RNA polymerase II, indirectly influencing D3Ertd751e's DNA-binding transcription activator activity and its regulatory role in transcription by RNA polymerase II. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB, functioning as both a kinase and RNA polymerase II inhibitor, directly targets CDK9. Its inhibition of CDK9 disrupts the phosphorylation process linked to RNA polymerase II, indirectly influencing D3Ertd751e's DNA-binding transcription activator activity and its role in the regulation of transcription by RNA polymerase II. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
CX-5461, primarily an RNA polymerase I inhibitor, directly targets RNA polymerase I. While its focus is on RNA polymerase I, CX-5461 indirectly influences RNA polymerase II and D3Ertd751e, affecting their transcriptional regulation. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Flavopiridol (Hydrochloride), a CDK inhibitor, directly targets CDK9. Its impact on CDK9 alters the phosphorylation process associated with RNA polymerase II, indirectly influencing D3Ertd751e's DNA-binding transcription activator activity and its regulatory role in transcription by RNA polymerase II. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
(+/-)-JQ1, a BET bromodomain inhibitor, directly targets BRD4. Its inhibition of BRD4 disrupts the interaction between BRD4 and acetylated histones, indirectly influencing D3Ertd751e's DNA-binding transcription activator activity and its role in the regulation of transcription by RNA polymerase II. | ||||||